Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000164997 | SCV000215691 | likely benign | Hereditary cancer-predisposing syndrome | 2014-08-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000197319 | SCV000254083 | likely benign | Ataxia-telangiectasia syndrome | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000164997 | SCV000682122 | likely benign | Hereditary cancer-predisposing syndrome | 2016-12-02 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001171665 | SCV001334470 | likely benign | not provided | 2022-09-01 | criteria provided, single submitter | clinical testing | ATM: BP4, BP7 |
Gene |
RCV001171665 | SCV001903072 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000164997 | SCV002535924 | likely benign | Hereditary cancer-predisposing syndrome | 2021-02-05 | criteria provided, single submitter | curation | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003235083 | SCV003934550 | likely benign | not specified | 2023-05-14 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001171665 | SCV004220973 | likely benign | not provided | 2022-06-03 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004589761 | SCV005084613 | benign | Familial cancer of breast | 2024-05-14 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |